John W. Meyer, President & COO, and Charles S. Arnold, Chairman & CEO of Stemtech Corporation STEK were recently interviewed by Benzinga.
Stemtech is a pioneer in the “stemceuticals” space. The company creates and markets nutritional supplements it says help spur the body’s natural production of adult stem cells. Stem cells play an integral role in the body’s ability to heal itself and repair damaged tissues.
Stemtech has a successful direct marketing approach that it believes can help it continue to grow as public awareness of stem cells grows as well.
Watch the full interview here:
Featured photo by Pawel Czerwinski on Unsplash.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.